Study on the Correlation between Blood Homocysteine Level and Cognitive Function in Patients with Cerebrovascular Disease
Dong LU,Wei ZHAO,Jing DU,Jie-Li GENG,Yao WANG,Wen-Wei CAO,Ling YU,Nan ZHI,Yan ZHOU,Qun,. XU
DOI: https://doi.org/10.3969/j.issn.1673-5765.2019.02.003
2019-01-01
Abstract:Objective HHcy is one of the independent risk factors for either cerebrovascular disease or cognitive impairment. The aim of this study is to investigate the relationship between blood Hcy level and early cognitive impairment in small vessel disease (SVD). Methods The data of SVD patients with no dementia from stroke clinic in our hospital for post-stroke follow-up were consecutively collected. The data included demographic information, vascular risk factors (VRFs) spectrum, cognitive assessment results and etc. The fasting blood Hcy was measured within 1 week after enrollment. HHcy was deflned as plasma Hcy level higher than 15 μmol/L. According to the Hcy test results, the patients were divided into HHcy group (Hcy>15?μmmol/L) and normal homocysteine (NHcy) group (Hcy≤15 μmol/L). Multimodal MRI was performed in all patients within 2 weeks after enrollment. The cognitive scores and imaging feature between the two groups were compared. The correlations of Hcy level with cognitive assessment results as well as with the imaging indices were analyzed. Results (1) A total of 81 SVD patients were enrolled in this study, with average age (64.3±7.4) years old, 65 male patients (80.2%) and 50 patients (61.7%) with mild cognitive impairment. (2) 30 patients (37.0%) in HHcy group and 51 ones (63.0%) in NHcy group. There were more smoking patients in HHcy than in NHcy group. There were no signiflcant difference in age, gender, education years between the two groups. (3) There were significant difference in the attention-executive function assessment such as trail making test B (TMT-B) (P=0.016), digital symbol substitution test (DSST) (P=0.013) and forward digital span test (DS-forward) (P=0.029) scores between the two groups. (4) The proportion of moderate to severe periventricular white matter lesions (PV-WMLs) (63.3% vs 39.2%, P=0.018), deep WMLs (60.0% vs 37.3%, P=0.036) and multiple cerebral microbleedings (CMBs) (36.7% vs 17.3%, P=0.047) in HHcy group were higher than those in NHcy group. The blood Hcy level was correlated with PV-WMLs (r=0.227, P=0.041). (5) After adjusting for PV-WMLs score, Hcy level was positively correlated with TMT-B time (r=0.278, P=0.013), negatively correlated with DSST (r=-0.354, P=0.004) and DS-forward (r=-0.366, P=0.001). Conclusions The blood Hcy level in SVD was signiflcantly correlated with attention-executive function and PV-WMLs. The blood Hcy level might be one of the markers of early cognitive impairment in SVD.